Viewing Study NCT06711705


Ignite Creation Date: 2025-12-25 @ 3:31 AM
Ignite Modification Date: 2026-03-07 @ 9:30 PM
Study NCT ID: NCT06711705
Status: RECRUITING
Last Update Posted: 2025-02-11
First Post: 2024-11-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Elranatamab in Relapsed/Refractory Multiple Myeloma
Sponsor: University of California, San Diego
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple Myeloma View
None Elranatamab View